Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a conjugate of the DNA topoisomerase I inhibitor DX-8951 and a cathepsin-cleavable antibody-drug conjugate (ADC) linker, designed for targeted cancer therapy applications.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a conjugate of the DNA topoisomerase I inhibitor DX-8951 and a cathepsin-cleavable antibody-drug conjugate (ADC) linker, designed for targeted cancer therapy applications. |
In vitro | ADC consists of an antibody to which the cytotoxic agent is attached via a linker [1]. |
Synonyms | MC-Val-Cit-PAB-DX8951 |
Molecular Weight | 1034.1 |
Formula | C53H60FN9O12 |
CAS No. | 2504068-28-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MC-Val-Cit-PAB-Exatecan 2504068-28-2 MC-Val-Cit-PAB-DX-8951 MC-Val-Cit-PAB-DX8951 MC-Val-Cit-PAB-DX 8951 inhibitor inhibit